IN8bio Inc. (INAB)
NASDAQ: INAB
· Real-Time Price · USD
2.35
-0.05 (-2.08%)
At close: Aug 15, 2025, 3:59 PM
2.29
-2.55%
After-hours: Aug 15, 2025, 06:39 PM EDT
IN8bio Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -5.09M | -5.55M | -6.16M | -7.09M | -8.63M | -8.56M | -7.6M | -7.17M | -7.71M | -7.53M | -7.8M | -7.4M | -7.18M | -6.14M | -5.85M | -3.39M | -3.05M | -2.36M |
Depreciation & Amortization | 541K | 669K | 702K | 87K | 631K | 632K | 627K | 647K | 637K | 590K | 351K | 246K | 274K | 232K | 234K | 199K | 190K | 165K |
Stock-Based Compensation | 955K | 831K | 825K | 2.93M | 1.17K | 1.24M | 1.25M | 1.24M | 1.02M | 859K | 922K | 897K | 884K | 764K | 965K | 477K | 392K | 361K |
Other Working Capital | -376K | 742K | 1.35M | 800K | 707K | -1.72M | 669K | -640K | 1.08M | -328K | -2.22M | -188K | 300K | 432K | 2.83M | -4.06M | 199K | -490K |
Other Non-Cash Items | 243K | n/a | n/a | -2.54M | 1.17M | n/a | 2.31M | 7.17M | -1.02M | n/a | 325K | 686K | 1.58M | 1.07M | 965K | 414.00 | -192 | 548K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -2.31M | -7.17M | 1.02M | n/a | -325K | -686K | -1.58M | n/a | -965K | n/a | n/a | n/a |
Change in Working Capital | -572K | 928K | 605K | 493K | 736K | -1.23M | 869K | -431K | 721K | -1.36M | -1.42M | 515K | 149K | 590K | 2.47M | -3.65M | 7K | -670K |
Operating Cash Flow | -3.93M | -3.12M | -4.03M | -6.11M | -6.09M | -7.92M | -4.85M | -5.71M | -5.34M | -7.44M | -7.95M | -5.74M | -5.87M | -4.56M | -2.18M | -6.37M | -2.46M | -2.51M |
Capital Expenditures | n/a | n/a | -33K | 83K | -83K | -71K | -72K | -77K | -22K | -429K | -1.26M | -1.76M | -425K | -253K | -156K | -153 | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16K | n/a | n/a | -245K | -309K | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | -33K | 83K | -83K | -71K | -72K | -77K | -22K | -429K | -1.26M | -1.76M | -425K | -253K | -156K | -153 | n/a | n/a |
Debt Repayment | -234K | -225K | -219K | -213K | -174K | -188K | -173K | -236K | -214K | -175K | -297K | -88K | -95K | -135K | -145K | -316K | -136K | -112K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 5.28M | -181K | 25K | n/a | 3.28M | n/a | n/a | n/a | n/a | n/a | 28K | 33K | -1.07M | -817K | -456K | -323K |
Financial Cash Flow | 5.27M | 3.89M | 11.19M | -105K | 3.38M | -277K | 13.35M | 1.65M | 11.49M | 547K | -253K | 9.41M | -67K | -102K | -1.21M | 35.19M | -592K | -435K |
Net Cash Flow | 1.34M | 771K | 7.13M | -6.22M | -2.8M | -8.27M | 8.43M | -4.14M | 6.13M | -7.32M | -9.46M | 1.91M | -6.36M | -4.91M | -3.4M | 28.68M | -3.05M | -2.94M |
Free Cash Flow | -3.93M | -3.12M | -4.06M | -6.03M | -6.17M | -7.99M | -4.92M | -5.79M | -5.36M | -7.87M | -9.21M | -7.5M | -6.3M | -4.81M | -2.33M | -6.37M | -2.46M | -2.51M |